广济药业 (000952.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(广济药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 165,737,525.72116,295,082.63180,161,008.71215,325,298.98178,582,464.34228,621,127.02115,290,588.81
 营业收入(元) 165,737,525.72116,295,082.63180,161,008.71215,325,298.98178,582,464.34228,621,127.02115,290,588.81
二、营业总成本(元) 223,872,624.23165,301,278.20239,269,664.37271,109,481.53223,589,176.96207,474,481.61160,483,094.07
 营业成本(元) 133,792,789.9371,406,059.95150,664,862.46163,760,959.74133,889,832.49143,758,830.8194,210,912.16
 研发费用(元) 16,281,435.1412,327,571.6816,095,943.1325,811,731.2121,800,011.1110,707,377.0116,432,520.06
 营业税金及附加(元) 3,389,154.933,147,612.023,537,499.473,743,734.353,070,068.782,805,000.444,067,186.92
 销售费用(元) 8,983,516.618,970,075.3110,435,235.889,610,741.626,701,240.1812,563,497.309,763,244.33
 管理费用(元) 47,432,108.1052,855,269.5250,216,465.9051,768,772.9742,618,694.0730,862,376.6930,938,038.61
 财务费用(元) 13,993,619.5216,594,689.728,319,657.5316,413,541.6415,509,330.336,777,399.365,071,191.99
  其中:利息费用(元) 14,927,276.1819,815,657.689,338,609.1517,221,807.5916,623,248.459,761,926.655,543,903.68
  其中:利息收入(元) 602,693.33435,018.07613,075.081,010,557.12938,177.36963,890.24549,769.12
 资产减值损失(元) -2,154,975.58-11,867,436.93-741,260.77-16,579,515.74-362,176.701,856,201.86821,014.24
 信用减值损失(元) 1,010,033.90627,042.85-1,245,071.833,307,201.66705,874.43-4,533,186.70492,630.31
三、其他经营收益
 加:投资收益(元) -719,161.48-2,069,120.49-855,481.24-3,034,025.24-1,895,150.25-2,107,386.50-2,987,048.92
  其中:对联营企业和合营企业的投资收益(元) -631,453.23-630,722.31-855,481.24-1,940,700.82-1,895,150.25-2,107,386.50-2,987,048.92
 资产处置收益(元) --84,381.47----
 其他收益(元) 5,539,092.992,528,601.035,679,908.264,202,233.201,134,998.10940,881.761,567,640.72
四、营业利润(元) -54,460,108.68-59,871,490.58-56,186,179.77-67,634,952.31-45,423,167.0417,303,155.83-45,298,268.91
 加:营业外收入(元) 46,452.92-13,313.111,073,404.48281,251.63903,834.2312,750.02306.00
 减:营业外支出(元) 1,562,459.78-65,991.3991,667.2794,413.1271,567.68125,314.84520,159.01
五、利润总额(元) -55,976,115.54-59,818,812.30-55,204,442.56-67,448,113.80-44,590,900.4917,190,591.01-45,818,121.92
 减:所得税费用(元) 917,324.161,075,495.26-535,008.0613,171,827.58-922,405.51-81,956.47-419,789.41
六、净利润(元) -56,893,439.70-60,894,307.56-54,669,434.50-80,619,941.38-43,668,494.9817,272,547.48-45,398,332.51
(一)按经营持续性分类
  持续经营净利润(元) -56,893,439.70-60,894,307.56-54,669,434.50-80,619,941.38-43,668,494.9817,272,547.48-45,398,332.51
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -51,930,265.16-56,137,109.82-50,508,221.70-73,271,898.66-41,171,630.6618,234,002.63-44,038,541.85
  少数股东损益(元) -4,963,174.54-4,757,197.74-4,161,212.80-7,348,042.72-2,496,864.32-961,455.15-1,359,790.66
 扣除非经常性损益后的净利润(元) -55,984,922.64-58,611,227.15-57,054,548.34-76,090,715.15-42,780,981.1217,517,882.27-44,933,230.08
七、每股收益
 一、基本每股收益(元) -0.15-0.16-0.14-0.21-0.120.05-0.12
 二、稀释每股收益(元) -0.15-0.16-0.14-0.21-0.120.05-0.12
八、其他综合收益(元) 2,909.0336.77-4,537.197,779.30-11,168.5314,623.822,736.71
 归属于母公司股东的其他综合收益(元) 2,909.0336.77-4,537.197,779.30-11,168.5314,623.822,736.71
九、综合收益总额(元) -56,890,530.67-60,894,270.79-54,673,971.69-80,612,162.08-43,679,663.5117,287,171.30-45,395,595.80
 归属于母公司所有者的综合收益总额(元) -51,927,356.13-56,137,073.05-50,512,758.89-73,264,119.36-41,182,799.1918,248,626.45-44,035,805.14
 归属于少数股东的综合收益总额(元) -4,963,174.54-4,757,197.74-4,161,212.80-7,348,042.72-2,496,864.32-961,455.15-1,359,790.66
公告日期 2024-10-312024-08-302024-04-262024-04-262023-10-212023-08-312023-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院